![]() | |
Formation | 2005 |
---|---|
Founder | Gary K. Michelson |
Headquarters | Los Angeles, California |
Award(s) | Michelson Prizes |
Website | https://www.michelsonmedicalresearch.org/ |
The Michelson Medical Research Foundation is a private, non-profit philanthropy founded by orthopedic spinal surgeon and inventor Gary K. Michelson. [1] [2] The foundation aims to solve global health issues by promoting the development of innovative ideas in medicine and bioscience. [3]
The foundation's co-chairs are Dr. Michelson and his wife, Alya Michelson.
The Michelson Medical Research Foundation was founded in 2005 and seeded with $100 million. [4] [5]
In 2017, the foundation, along with the Human Vaccines Project, established the Michelson Prizes: Next Generation Grants, a $20 million initiative to advance innovation in the field of vaccines and immunotherapies through grants. [6] [7] The inaugural winners of the $150,000 awards in June 2018 included the University of Melbourne's Dr. Laura Mackay, Monash University's Dr. Patricia Illing, and Stanford University School of Medicine's Dr. Ansuman Satpathy. [8] [9] 2022 grant winners included Dr. Noam Auslander and Dr. Brittany Hartwell of the University of Minnesota. [10] The 2022 Michelson Philanthropies & Science Prize for Immunology was awarded to Dr. Paul Bastard. [11] Dr. Siyuan Ding of Washington University in St. Louis, Weill Cornell Medicine's Dr. Claire Otero, and Rockefeller University's Dr. Dennis Schaefer-Babajew were the Next Generation Grant winners of 2023. [12]
2019 Next Generation Grant winners Dr. Murad Mamedov and Dr. Avinash Das Sahu collaborated on a study, published in August 2023, to identify how gamma-delta T cells recognize and destroy cancer cells. [13]
2024 Next Generation Grant winner Dr. Omar Abudayyeh, along with Jonathan Gootenberg are developing RNA-editing tools, focusing on a set of enzymes called adenosine deaminases (ADARs) that bind to double-stranded RNA molecules and alter the letters of its genetic code. The $150,000 grant is funding Dr. Abudayyeh's effort to deliver tumor-specific therapies directly to cancerous cells while minimizing potential side effects and maximizing efficacy. [14]
Alongside FEMA, UCLA Research Park, future home of the California Institute for Immunology and Immunotherapy, was converted into a disaster relief center in January 2025 to support those affected by the wildfires. [15] [16]
Beneficiaries of the Michelson Medical Research Foundation include:
{{cite web}}
: CS1 maint: multiple names: authors list (link)